Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture. (2017)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/btpr.2492
PubMed Identifier: 28480535
Publication URI: http://europepmc.org/abstract/MED/28480535
Type: Journal Article/Review
Volume: 33
Parent Publication: Biotechnology progress
Issue: 4
ISSN: 1520-6033